Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Qi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Isothiocyanates, Stomach Neoplasms, B7-H1 Antigen, Sulfoxides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province "The 14th Five-year Plan" Key Discipline-Public Health and Preventive Medicine.
Abstract (Originalsprache)
Sulforaphane (SFN) exerts anticancer effect on various cancers including gastric cancer. However, the regulatory effect of SFN on programmed death‐ligand 1 (PD‐L1) and checkpoint blockade therapy in gastric cancer have not been elucidated. Here we demonstrated that SFN suppressed gastric cancer cell growth both in vitro and in vivo study. SFN upregulated PD‐L1 expression through activating ΔNP63α in gastric cancer cells. Further, we found that SFN impaired the anticancer effect of anti‐PD‐L1 monoclonal antibody (α‐PD‐L1 mab) on gastric cancer cells. These results uncover a novel PD‐L1 regulatory mechanism and the double‐edged role of SFN in gastric cancer intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Yinzhou Center for Disease Control and Prevention, Ningbo, China.
- Department of Nutrition, School of Acupuncture and Tuina, Nanjing University of Chinese Medicine, Nanjing, China.
- The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Nutrition and Food Safety, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
- Department of Thoracic Surgery, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Caiyun Zhong
Förderung
- National Natural Science Foundation of China
- Jiangsu Province "The 14th Five-year Plan" Key Discipline-Public Health and Preventive Medicine
Zitieren
APA
Zhang, Q., Yang, C., Ma, Z., Ye, L., Wu, Y., Zhong, C., Shi, Y., & Zhu, M. (2024). Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23749
Vancouver
Zhang Q, Yang C, Ma Z, Ye L, Wu Y, Zhong C, et al. Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23749
BibTeX
@article{Zhang2024,
author = {Zhang, Qi and Yang, Chenying and Ma, Zhijian and Ye, Liangwen and Wu, Yunfeng and Zhong, Caiyun and Shi, Ye and Zhu, Mingming},
title = {Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23749}
}
EUVIMED